Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunphenon EGCG in Progressive MS
NCT00799890Phase 3Completed
- Start
- May 2009
- Primary completion
- Mar 2016
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Sunphenon EGCG in primary progressive multiple sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS). Started May 2009; status: completed.
02
Drugs
Sunphenon EGCG
03
Conditions
primary progressive multiple sclerosis (PPMS)Secondary Progressive Multiple Sclerosis (SPMS)
Beyond the preview
Go deeper on NCT00799890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00799890.